{
    "complex": true,
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "ucits": true,
    "type": "ETF",
    "complex_factors": [
        "Synthetic replication using swaps",
        "Counterparty risk exposure",
        "Potential for significant tracking error"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via an over-the-counter swap contract with counterparties (Morgan Stanley Bank AG and Societe Generale), which introduces counterparty risk and potential tracking error. While the fund is UCITS-compliant and has a straightforward equity exposure, the use of derivatives for replication (rather than direct physical holding) and the associated risks (counterparty, liquidity, and replication risks) make it complex under MiFID II. The fact sheet confirms the synthetic replication method and highlights counterparty risk, which is a key complexity factor. The risk profile is not inherently high (SRRI 3), but the derivative-based structure and counterparty exposure are sufficient to classify it as complex.",
    "confidence": 90
}